Proteomic characterization of high-density lipoprotein particles in patients with non-alcoholic fatty liver disease.
Proteomic characterization of high-density lipoprotein particles in patients with non-alcoholic fatty liver disease.
复制标题
DOI：
10.1186/s12014-018-9186-0
复制
发表时间：
2018
影响因子：
3.8
通讯作者：
Olivier M
中科院分区：
文献类型：
--
作者：
Rao PK;Merath K;Drigalenko E;Jadhav AYL;Komorowski RA;Goldblatt MI;Rohatgi A;Sarzynski MA;Gawrieh S;Olivier M
Metabolic diseases such as obesity and diabetes are associated with changes in high-density lipoprotein (HDL) particles, including changes in particle size and protein composition, often resulting in abnormal function. Recent studies suggested that patients with non-alcoholic fatty liver disease (NAFLD), including individuals with non-alcoholic steatohepatitis (NASH), have smaller HDL particles when compared to individuals without liver pathologies. However, no studies have investigated potential changes in HDL particle protein composition in patients with NAFLD, in addition to changes related to obesity, to explore putative functional changes of HDL which may increase the risk of cardiovascular complications. From a cohort of morbidly obese females who were diagnosed with simple steatosis (SS), NASH, or normal liver histology, we selected five matched individuals from each condition for a preliminary pilot HDL proteome analysis. HDL particles were enriched using size-exclusion chromatography, and the proteome of the resulting fraction was analyzed by liquid chromatography tandem mass spectrometry. Differences in the proteomes between the three conditions (normal, SS, NASH) were assessed using label-free quantitative analysis. Gene ontology term analysis was performed to assess the potential impact of proteomic changes on specific functions of HDL particles. Of the 95 proteins identified, 12 proteins showed nominally significant differences between the three conditions. Gene ontology term analysis revealed that severity of the liver pathology may significantly impact the anti-thrombotic functions of HDL particles, as suggested by changes in the abundance of HDL-associated proteins such as antithrombin III and plasminogen. The pilot data from this study suggest that changes in the HDL proteome may impact the functionality of HDL particles in NAFLD and NASH patients. These proteome changes may alter cardio-protective properties of HDL, potentially contributing to the increased cardiovascular disease risk in affected individuals. Further validation of these protein changes by orthogonal approaches is key to confirming the role of alterations in the HDL proteome in NAFLD and NASH. This will help elucidate the mechanistic effects of the altered HDL proteome on cardioprotective properties of HDL particles. The online version of this article (10.1186/s12014-018-9186-0) contains supplementary material, which is available to authorized users.
登录
查看更多内容
影响因子：
14.9
作者：
Kamburov A;Stelzl U;Lehrach H;Herwig R
通讯作者：
Herwig R
影响因子：
2.4
作者：
Poynard T;Ratziu V;Charlotte F;Messous D;Munteanu M;Imbert-Bismut F;Massard J;Bonyhay L;Tahiri M;Thabut D;Cadranel JF;Le Bail B;de Ledinghen V;LIDO Study Group;CYTOL study group
通讯作者：
CYTOL study group
影响因子：
4.4
作者：
Cox, Juergen;Neuhauser, Nadin;Mann, Matthias
通讯作者：
Mann, Matthias
影响因子：
37.8
作者：
Riwanto, Meliana;Rohrer, Lucia;Landmesser, Ulf
通讯作者：
Landmesser, Ulf
影响因子：
2
作者：
Osei, Michael;Griffin, Julian L.;Koulman, Albert
通讯作者：
Koulman, Albert